Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
13 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
European Haemophilia Consortium from Brussel, company number BE0887106966, closed financial year 2025 with a result of € -258,102 after tax. For that financial year European Haemophilia Consortium recorded a gross margin of € 367,082 and equity of € 2 million. Compared with financial year 2024, the result moved from € 3,417 to € -258,102. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 3, 2026.
€ 2 million
▼ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -258,102
▼ still € 3,417 profit in 2024
Profit after tax over the fiscal year.
€ 1.6 million
▼ 17% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
€ 553,194
▲ 43% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 73,551
▲ 84% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 103,127
▲ 28% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 838,617 | € 457,367 | € 367,082 | ▼ 20% |
| Profit after taxes | € 17,205 | € 3,417 | € -258,102 | ▼ € 261,519 |
| Equity | € 2,224,168 | € 2,227,585 | € 1,969,483 | ▼ 12% |
| Total debts | € 620,314 | € 263,589 | € 387,510 | ▲ 47% |
| Cash | € 1,799,141 | € 1,961,525 | € 1,632,662 | ▼ 17% |
| Land & buildings | € 438,633 | € 402,779 | € 366,927 | ▼ 9% |
| Retained profit | € 2,214,748 | € 2,218,165 | € 1,960,063 | ▼ 12% |
| Balance sheet total | € 2,844,482 | € 2,491,174 | € 2,356,993 | ▼ 5% |
Key figures of European Haemophilia Consortium, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to European Haemophilia Consortium?
What happened at European Haemophilia Consortium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 258,102 (▼ € 261,519 vs 2024). filed late Source: NBB ↗
- New establishment in Brussel. KBO
- Start of the company according to the CBE. KBO
In short
From € 17,205 profit in 2023 to € 258,102 loss in 2025.
Paid € 1,748 in corporate taxes since 2023.
Best year ever: 2023, with € 17,205 profit.
A new publication or filing at European Haemophilia Consortium? We notify you, reason included.
Follow European Haemophilia ConsortiumDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Wetstraat 28 box 3
1040 Brussel
Grasmarkt 105 box 14
1000 Brussel
Active since 11 June 2015
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 13 companies are registered at this address.
All companies at this address →Litton Systems S.A./N.V.
B.M.I. CONCEPT
€ 98,580 gross margin · 2025
ZANDGROEVEN POELS
Groupement socio-culturel des Administrations locales et régionales - Social-culturele Groepering der Lokale en Regionale Besturen
VIADUC
+8 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0887.106.966
- VAT number
- BE 0887.106.966
- Registered office
- Wetstraat 28 bus 3, 1040 Brussel
- Names & denominations
- European Haemophilia Consortium · EHC · Consortium Européen de l'Hémophilie
- Enterprise type
- Rechtspersoon
- Legal form
- International non-profit association
- Legal situation
- Normale toestand
- Start date
- 8 February 2007
- Peppol
- Active · Active since 20 Nov 2020
- Activities · NACE
Verenigingen op het vlak van ziektepreventie en gezondheidsbevordering
Markt- en opinieonderzoek
Marktonderzoekbureaus